从2023年开始,Medicare对药物费用实行每年2 000美元的上限,使数百万人受益。 Starting 2023, Medicare introduces a $2,000 annual cap on drug costs, benefiting millions.

自2023年1月1日起,《降低通货膨胀法》将规定每年2 000美元的医药处方药费用上限,为癌症病人和服高药费的人提供大量救济。 Starting January 1, 2023, the Inflation Reduction Act will introduce a $2,000 annual cap on Medicare prescription drug costs, providing significant relief to cancer patients and others who struggle with high medication prices. 该上限适用于D部分《医疗保健计划》规定的所有药物,允许注册者全年支付。 The cap applies to all drugs under Medicare Part D and allows enrollees to spread payments throughout the year. 根据美国退休人员协会的一份报告,预计到2025年,将有320万医疗保险受益人受益,到2029年将增至410万。 According to an AARP report, 3.2 million Medicare recipients are expected to benefit in 2025, rising to 4.1 million by 2029.